Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Stimulated CD4+ T lymphocytes can differentiate into effector T cell (Teff) or inducible regulatory T cell (Treg) subsets with specific immunological roles. We show that Teff and Treg require distinct metabolic programs to support these functions. Th1, Th2, and Th17 cells expressed high surface levels of the glucose transporter Glut1 and were highly glycolytic. Treg, in contrast, expressed low levels of Glut1 and had high lipid oxidation rates. Consistent with glycolysis and lipid oxidation promoting Teff and Treg, respectively, Teff were selectively increased in Glut1 transgenic mice and reliant on glucose metabolism, whereas Treg had activated AMP-activated protein kinase and were dependent on lipid oxidation. Importantly, AMP-activated protein kinase stimulation was sufficient to decrease Glut1 and increase Treg generation in an asthma model. These data demonstrate that CD4+ T cell subsets require distinct metabolic programs that can be manipulated in vivo to control Treg and Teff development in inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast to Treg cells, TH2 cells were shown to display an increased glycolytic rate44.”
From Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells (2017) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“This increased mitochondrial metabolism in Tregs was found to be due to increased AMPK-dependent fatty acid oxidation (MacIver et al., 2011; Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“Different subsets of T cells, as well as different stages following T cell activation, are characterized by the use of different metabolic pathways [97, 108, 109].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [108]
In the citing paper
“Tregs have elevated levels of oxidative phosphorylation and decreased glycolytic flux compared to Th17 cells (Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
In the citing paper
“This was first demonstrated by Michalek et al. (34), who determined that proinflammatory CD4+ T helper (TH) cells (TH1, TH2, and TH17 lineages) displayed a strong bias toward glycolysis over mitochondrial metabolism, whereas induced CD4+ T regulatory (Treg) lineage cells displayed a mixed metabolism involving glycolysis, lipid oxidation, and OXPHOS.”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 1×
“To meet these requirements, activated T cells decrease lipid oxidation and undergo a rapid increase in glycolysis (4).”
BackgroundmTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575 · cited 2×
“At the conclusion of an immune response, decreased glycolysis and increased lipid oxidation can favor the enrichment of long-lived CD8 memory cells (5, 6).”
BackgroundEnhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559 · cited 4×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodInfluentialThe mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., & Powell, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,284
Jacobs, S. R., Herman, C. E., MacIver, N. J., Wofford, J. A., Wieman, H. L., Hammen, J. J., & Rathmell, J. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4476 · Cited by 850 · cited 5×
“1G) and Ig deposition in the kidneys (3).”
BackgroundSelf-citationAMP-Activated Protein Kinase – Development of the Energy Sensor Concept
Hardie, D. G., Hawley, S. A., & Scott, J. W. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108944 · Cited by 813 · cited 1×
“In contrast, the AMPK pathway acts to inhibit mTOR by suppressing mTOR signaling and to promote mitochondrial oxidative metabolism rather than glycolysis (10).”
BackgroundThe AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
Haxhinasto, S., Mathis, D., & Benoist, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071477 · Cited by 737 · cited 1×
“Inhibition of mTOR can result in the elevated oxidation of exogenous FA (15) and promote Treg differentiation (16).”
BackgroundStability of the Regulatory T Cell Lineage in Vivo
Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., & Rudensky, A. Y. (2010) · Science · doi:10.1126/science.1191996 · Cited by 730 · cited 1×
“stable pool of important immune regulatory cells (18), and lipid oxidation may be central in contributing to their maintenance and self-renewal.”
BackgroundWieman, H. L., Wofford, J. A., & Rathmell, J. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-07-0593 · Cited by 593 · cited 3×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodSelf-citation
Cited by
Items 601–700 of 1,005
Yang, L., Zhao, N., Wu, Y., Yang, S., Wu, Q., Dong, Q., & Du, Y. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad029 · Cited by 69
Metabolic regulation of organelle homeostasis in lupus T cells
Caza, T. N., Talabér, G., & Perl, A. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.07.001 · Cited by 66
“Enhanced mTORC1 activity and reduced lipid oxidation suppress activation of cAMP-associated protein kinase (AMPK) [88] required for regulatory T cell metabolism, shifting the balance to support effector T over regulatory T cell function [87].”
Basu, S., Hubbard, B., & Shevach, E. M. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ab0514-273rr · Cited by 64
“Th1, Th2, and Th17 cells all had high surface expression of Glut 1, whereas iTreg expressed low levels and used lipid oxidation [11, 12].”
BackgroundThe Functional Stability of FOXP3 and RORγt in Treg and Th17 and Their Therapeutic Applications
Ren, J., & Li, B. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2016.10.002 · Cited by 70
Wu, W., Sun, H.-W., Chen, J., Ouyang, H., Yu, X.-J., Chen, H., Shuang, Z., Shi, M., Wang, Z., & Zheng, L. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0902 · Cited by 74
“They have low glycolysis rates, but sustain high mitochondrial biogenesis, relying on FAO to exert their immunosuppressive effect (22, 23).”
BackgroundZahoor, I., Suhail, H., Datta, I., Ahmed, M. E., Poisson, L., Waters, J., Rashid, F., Rui, B., Singh, J., Cerghet, M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123265119 · Cited by 66
“Metabolic reprogramming within the inflammatory cells, such as activated macrophages and CD4 cells, is well documented, where a switch to glycolysis for energy generation is essentially required for their cellular functions (Michalek et al., 2011).”
BackgroundControl of the Antitumor Immune Response by Cancer Metabolism
Domblides, C., Lartigue, L., & Faustin, B. (2019) · Cells · doi:10.3390/cells8020104 · Cited by 68
“In contrast, regulatory T cells (Treg) do not seem to be impaired by lactate and acidification, because of a different metabolism, based on fatty acid oxidation (FAO) [54].”
InfluentialMorano, A. E. V. A., Dorneles, G. P., Peres, A., & Lira, F. S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29228 · Cited by 73
“On the other hand, alternatively activated macrophages (“M2”) are less inflammatory than M1 macrophages and commonly related to tissue regeneration and the maintenance of physiological home- ostasis (Mills et al., 2000).”
BackgroundImmune metabolism in PD-1 blockade-based cancer immunotherapy
Kumar, A., & Chamoto, K. (2020) · International Immunology · doi:10.1093/intimm/dxaa046 · Cited by 74
Dietary Intervention Impacts Immune Cell Functions and Dynamics by Inducing Metabolic Rewiring
Okawa, T., Nagai, M., & Hase, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.623989 · Cited by 63
Effects of fatty acids on T cell function: role in atherosclerosis
Reilly, N. A., Lutgens, E., Kuiper, J., Heijmans, B. T., & Jukema, J. W. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00582-9 · Cited by 68
Tissue resident regulatory T cells: novel therapeutic targets for human disease
Zhou, X., Tang, J., Cao, H., Fan, H., & Li, B. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.23 · Cited by 72
Waickman, A. T., & Powell, J. D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103143 · Cited by 71
“tion in part by their ability to regulate mTOR (51, 55).”
BackgroundMitochondrial Metabolism in T Cell Activation and Senescence: A Mini-Review
Ron-Harel, N., Sharpe, A. H., & Haigis, M. C. (2015) · Gerontology · doi:10.1159/000362502 · Cited by 62
Obesity's effect on asthma extends to diagnostic criteria
Lugogo, N. L., Green, C. L., Agada, N. O., Zhang, S., Meghdadpour, S., Zhou, R., Yang, S., Anstrom, K. J., Israel, E., Martin, R. J., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.04.047 · Cited by 64
“001* Age at asthma diagnosis (y) 9 (4-18) 12 (5-24) 13 (5-25) .”
Regulation of fatty acid synthesis in immune cells
Qian, X., Yang, Z., Mao, E., & Chen, E. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12713 · Cited by 70
“In Th1, Th2, and Th17 cells, mTOR is also a major sensor and regulator of cellular metabolism signalling because it induces enhanced expression of glucose transporter 1 (GLUT1) in the glycolytic pathway.(59) In Th17 cells, the inhibition of ACC1, which produces malonyl‐CoA as a building block for new fatty acids, is a…”
BackgroundDevelopment of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies
Kishimoto, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00969 · Cited by 63
“Treg activation and differentiation (28, 39, 40).”
BackgroundTargeting metabolism to enhance immunotherapy within tumor microenvironment
Liang, X., Chen, X., Yan, Y., Cheng, A.-Y., Lin, J.-Y., Jiang, Y.-X., Chen, H., Jin, J., & Luan, X. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01304-w · Cited by 76
Normal and cancer cell metabolism: lymphocytes and lymphoma
Altman, B. J., & Dang, C. V. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08651.x · Cited by 62
Empowering Regulatory T Cells in Autoimmunity
Kasper, I. R., Apostolidis, S. A., Sharabi, A., & Tsokos, G. C. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.07.003 · Cited by 69
“In contrast, in order to maintain functional capacity in Tregs, mTOR appears to be required not for glycolysis but rather, for lipogenesis [55] [56].”
BackgroundEnhanced glycolysis contributes to the pathogenesis of experimental autoimmune neuritis
Liu, R.-T., Zhang, M., Yang, C.-L., Zhang, P., Zhang, N., Du, T., Ge, M., Yue, L.-T., Li, X., Li, H., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1095-7 · Cited by 67
“to meet their energetic needs, while the principal antiinflammatory cell, Treg cells, depends on lipid metabolism and could expand and function even without glucose [8].”
Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting
Kumar, V. (2018) · Inflammation · doi:10.1007/s10753-018-0939-8 · Cited by 71
Hargadon, K. M. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.37 · Cited by 67
A novel TNFR2 agonist antibody expands highly potent regulatory T cells
Torrey, H., Kühtreiber, W. M., Okubo, Y., Tran, L., Case, K. B., Zheng, H., Vanamee, É. S., & Faustman, D. L. (2020) · Science Signaling · doi:10.1126/scisignal.aba9600 · Cited by 64
Lipid Metabolism: Immune Regulation and Therapeutic Prospectives in Systemic Lupus Erythematosus
Sun, W., Li, P., Cai, J., Ma, J., Zhang, X., Song, Y., & Liu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.860586 · Cited by 72
A deubiquitination module essential for T reg fitness in the tumor microenvironment
Montauti, E. I., Weinberg, S. E., Chu, P., Chaudhuri, S. M., Mani, N. L., Iyer, R., Zhou, Y., Zhang, Y., Liu, C., Xin, C., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo4116 · Cited by 71
Melis, D., Carbone, F., Minopoli, G., Rocca, C. L., Perna, F., Rosa, V. D., Galgani, M., Andria, G., Parenti, G., & Matarese, G. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601946 · Cited by 60
“In this context, although Tregs generated in vitro in the presence of TGF-b were shown to rely mainly on lipid oxidation (14), recent reports have also shown a major role for glycolysis in the induction and suppressive function of human and mouse Tregs (15, 16), given the capacity of the glycolytic enzyme enolase-1 to…”
Metabolic Adaptations of CD4+ T Cells in Inflammatory Disease
Dumitru, C., Kabat, A. M., & Maloy, K. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00540 · Cited by 74
Immunometabolism and autoimmunity
Freitag, J., Berod, L., Kamradt, T., & Sparwasser, T. D. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.77 · Cited by 67
Kamyshnyi, O., Matskevych, V. M., Lenchuk, T., Strilbytska, O. M., Storey, K. B., & Lushchak, O. V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112230 · Cited by 66
“level of Glut1 expression and extensively use glycolysis for energy production [81].”
Metabolism Characteristics of Th17 and Regulatory T Cells in Autoimmune Diseases
Qin, Y., Gao, C., & Luo, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.828191 · Cited by 77
Grajchen, E., Loix, M., Baeten, P., Côrte‐Real, B. F., Hamad, I., Vanherle, S., Haidar, M., Dehairs, J., Broos, J. Y., Ntambi, J. M., et al. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01011-2 · Cited by 70
“attenuate neuroinflammation and favor the differentiation of Tregs at the expense of Th17 cells (13-18).”
BackgroundImmunometabolism in the pathogenesis of asthma
Qin, Z., Chen, Y., Wang, Y., Xu, Y., Liu, T., Mu, Q., & Huang, C. (2023) · Immunology · doi:10.1111/imm.13688 · Cited by 70
“While Treg cells conduct enhanced OxPhos relying on highly activated AMP-activated protein kinase (AMPK), Th1, Th2 and Th17 cells do perform an augmented glycolysis based on the increased glucose transporter Glut1 [36].”
BackgroundInfluentialShi, Z., Hu, C., Zheng, X., Sun, C., & Li, Q. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00519-1 · Cited by 75
“However, Treg cells are not affected by pH value and lactate levels [213].”
BackgroundReenergizing T cell anti-tumor immunity by harnessing immunometabolic checkpoints and machineries
Ho, P.-C., & Kaech, S. M. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.04.003 · Cited by 59
Autophagy and T cell metabolism
Dowling, S. D., & Macián, F. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.033 · Cited by 63
“Th1, Th2, and Th17 cells (effector T cells, Teffs) express high levels of the glucose transporter Glut1 and have increased glycolytic activity compared to regulatory T cells (Tregs), which have increased rates of lipid oxidation [21].”
BackgroundLe Menn, G., & Neels, J. G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061575 · Cited by 60
“In this regard, studies showed that Th1, Th2, and Th17 cells use glycolysis to meet their energy demands, whereas Tregs have high lipid oxidation rates [22,23].”
BackgroundSirtuins and Immuno-Metabolism of Sepsis
Wang, X., Buechler, N. L., Woodruff, A. G., Long, D. L., Zabalawi, M., Yoza, B. K., McCall, C. E., & Vachharajani, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092738 · Cited by 60
NK Cell Metabolism and TGFβ – Implications for Immunotherapy
Slattery, K., & Gardiner, C. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02915 · Cited by 70
IL-1β induced HIF-1α inhibits the differentiation of human FOXP3+ T cells
Feldhoff, L., Rueda, C. M., Moreno‐Fernandez, M. E., Sauer, J., Jackson, C. M., Chougnet, C. A., & Rupp, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-00508-x · Cited by 63
Metabolic reprogramming as a key regulator in the pathogenesis of rheumatoid arthritis
Cai, W., Yu, Y., Zong, S.-Y., & Wei, F. (2020) · Inflammation Research · doi:10.1007/s00011-020-01391-5 · Cited by 66
Metabolism and immunity in breast cancer
Zhang, D., Xu, X., & Ye, Q. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0793-6 · Cited by 63
Goals in Nutrition Science 2020-2025
Bassaganya-Riera, J., Berry, E. M., Blaak, E. E., Burlingame, B., le Coutre, J., van Eden, W., El‐Sohemy, A., German, J. B., Knorr, D., Lacroix, C., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2020.606378 · Cited by 81
“, Th1 and Th17 cells tied to the pathogenesis of autoimmune disease) utilize aerobic glycolysis to meet the rapid, high-energy demand of cytokine production and post-transcriptional control of phenotype, thereby deriving more ATP from glycolysis (40, 59, 60).”
BackgroundImmunometabolism in biofilm infection: lessons from cancer
Mirzaei, R., Sabokroo, N., Ahmadyousefi, Y., Motamedi, H., & Karampoor, S. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00435-2 · Cited by 63
Fatty acid oxidation in immune function
Kemp, F., Braverman, E. L., & Byersdorfer, C. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1420336 · Cited by 66
Signals and pathways controlling regulatory T cells
Huynh, A., Zhang, R., & Turka, L. A. (2014) · Immunological Reviews · doi:10.1111/imr.12148 · Cited by 66
“However, Tregs have recently been shown to use lipid oxidation as a form of metabolism, with high activity of the AMP-activated protein kinase (AMPK) pathway which inhibits mTOR signals (147, 157).”
BackgroundFunctional and Genomic Architecture of Borrelia burgdorferi -Induced Cytokine Responses in Humans
Oosting, M., Kerstholt, M., ter Horst, R., Li, Y., Deelen, P., Smeekens, S. P., Jaeger, M., Lachmandas, E., Vrijmoeth, H. D., Lupșe, M. S., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.10.006 · Cited by 65
“Our findings showing a stronger effect of the HIF1AN eQTL on IL-17 and IL-22 rather than on IFN-g are supported by Michalek et al. (2011), showing a higher glycolytic rate in Th17 cells compared to Th1 cells, which could explain the higher sensitivity to changes in glycolytic flux.”
BackgroundResultSimilarities in the Metabolic Reprogramming of Immune System and Endothelium
Tang, C.-Y., & Mauro, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00837 · Cited by 65
Extracellular Lactate: A Novel Measure of T Cell Proliferation
Grist, J. T., Jarvis, L. B., Georgieva, Z., Thompson, S., Kaur Sandhu, H., Burling, K., Clarke, A., Jackson, S., Wills, M., Gallagher, F. A., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700886 · Cited by 59
“In keeping with the literature (10), under normoxic conditions”
BackgroundSuper-Treg: Toward a New Era of Adoptive Treg Therapy Enabled by Genetic Modifications
Amini, L., Greig, J., Schmueck‐Henneresse, M., Volk, H., Bézie, S., Reinke, P., Guillonneau, C., Wagner, D. L., & Anegón, I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.611638 · Cited by 62
Obesity and the risk of Multiple Sclerosis. The role of Leptin
Marrodan, M., Farez, M. F., Balbuena Aguirre, M. E., & Correale, J. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51291 · Cited by 58
“Cell metabolism is critical to regulate cell fate, since distinct metabolic programs may direct toward either effector or regulatory functions.(50) At physiological concentration leptin increases glucose uptake by CD4CD25 Treg cells, whereas in conditions in which its levels rise high, it is able to significantly inhi…”
BackgroundPark, S. Y., Jing, X., Gupta, D., & Dziarski, R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202675 · Cited by 63
“For example, generation of Treg cells is promoted by fatty acids, whereas generation of Th cells is promoted by glucose (63).”
BackgroundmTOR and metabolic regulation of conventional and regulatory T cells
Liu, C., Chapman, N. M., Karmaus, P. W. F., Zeng, H., & Chi, H. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ri0814-408r · Cited by 63
Dorneles, G. P., Passos, A. A. Z. D., Romão, P. R. T., & Peres, A. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200305125210 · Cited by 65
Turbitt, W. J., Rosean, C. B., Weber, K. S., & Norian, L. A. (2020) · Immunological Reviews · doi:10.1111/imr.12849 · Cited by 62
Lu, P., Chen, L., Wan, J., Liu, W., Lou, S., & Shen, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1179877 · Cited by 66
“palmitate oxidation) to meet their energy needs (37, 38).”
BackgroundForesto‐Neto, O., Menezes-Silva, L., Leite, J. A., Andrade-Silva, M., & Câmara, N. O. S. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090122-045843 · Cited by 75
Immunometabolism in cancer: basic mechanisms and new targeting strategy
Su, R., Shao, Y., Huang, M., Liu, D., Yu, H., & Qiu, Y. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02006-2 · Cited by 66
“In contrast to these two types of cells, regulatory T cells and memory T cells continue to derive most of the energy from the oxidative phosphorylation process, even after activation, when they preferentially consume fatty acids rather than amino acids and glucose [28, 29].”
ResultNutrient Sensing via mTOR in T Cells Maintains a Tolerogenic Microenvironment
Howie, D., Waldmann, H., & Cobbold, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00409 · Cited by 57
Attenuation of AMPK signaling by ROQUIN promotes T follicular helper cell formation
Ramiscal, R. R., Parish, I. A., Lee-Young, R. S., Babon, J. J., Blagih, J., Pratama, A., Martin, J., Hawley, N., Cappello, J. Y., Nieto, P. F., et al. (2015) · eLife · doi:10.7554/elife.08698 · Cited by 57
“In CD4 + T cells, ligation of PD1 couples mTOR signals ( Francisco et al., 2009 ) and also restricts cellular glycolysis ( Patsoukis et al., 2015 ; Parry et al., 2005 ) in a similar manner to AMPK a 1 activity ( MacIver et al., 2011 ; Michalek et al., 2011 ).”
BackgroundInduction of Colonic Regulatory T Cells by Mesalamine by Activating the Aryl Hydrocarbon Receptor
Oh‐oka, K., Kojima, Y., Uchida, K., Yoda, K., Ishimaru, K., Nakajima, S., Hemmi, J., Kano, H., Fujii‐Kuriyama, Y., Katoh, R., et al. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.03.010 · Cited by 66
Wan, H., Xu, B., Zhu, N., & Ren, B. (2019) · Tumori Journal · doi:10.1177/0300891619868287 · Cited by 61
Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer: Combination Therapy in the First-Line Setting
Aggen, D. H., Drake, C. G., & Rini, B. I. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3323 · Cited by 60
“Similarly, attenuation of glycolysis in CD4 T cells, which may or may not be independent of PD-1 signaling, promotes regulatory T cell commitment (41).”
BackgroundThe Importance of Metabolism for Immune Homeostasis in Allergic Diseases
Rodríguez‐Coira, J., Villaseñor, A., Izquierdo, E., Huang, M., Barker‐Tejeda, T. C., Radzikowska, U., Sokołowska, M., & Barber, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.692004 · Cited by 62
Immunometabolism at the Heart of Cardiovascular Disease
DeBerge, M., Chaudhary, R. K., Schroth, S. L., & Thorp, E. B. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.12.010 · Cited by 65
Mitochondria during T cell aging
Escrig-Larena, J. I., Delgado-Pulido, S., & Mittelbrunn, M. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101808 · Cited by 65
Saadh, M. J., Allela, O. Q. B., Ballal, S., Mahdi, M. S., Chahar, M., Verma, R., Al-Hussein, R. K. A., Adil, M., Jawad, M. J., & Al-Nuaimi, A. M. A. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152398 · Cited by 74
Eleftheriadis, T., Pissas, G., Antoniadi, G., Liakopoulos, V., & Stefanidis, I. (2015) · Immunology · doi:10.1111/imm.12502 · Cited by 56
Changing appetites: the adaptive advantages of fuel choice
Stanley, I. A., Ribeiro, S. M., Giménez-Cassina, A., Norberg, E., & Danial, N. N. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.07.010 · Cited by 56
King, B. C., Esguerra, J. L. S., Golec, E., Eliasson, L., Kemper, C., & Blom, A. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1500516 · Cited by 56
Fan, M. Y., & Turka, L. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00069 · Cited by 62
Cao, J., Yang, X. L., Li, J., Wu, H., Li, P., Yao, Z., Dong, Z., & Tian, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01533 · Cited by 62
Extracellular Vesicles and Cancer: A Focus on Metabolism, Cytokines, and Immunity
Lucchetti, D., Tenore, C. R., Colella, F., & Sgambato, A. (2020) · Cancers · doi:10.3390/cancers12010171 · Cited by 62
“Naïve T cells can reprogram their metabolic pathway by the Warburg effect phenomenon using glucose for glycolysis [117].”
BackgroundFatty acid oxidation: driver of lymph node metastasis
Li, M., Xian, H.-C., Tang, Y.-J., Liang, X., & Tang, Y. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02057-w · Cited by 68
PARK7/DJ-1 promotes pyruvate dehydrogenase activity and maintains Treg homeostasis during ageing
Danileviciute, E., Zeng, N., Capelle, C., Paczia, N., Gillespie, M. A. K., Kurniawan, H., Benzarti, M., Merz, M. P., Coowar, D., Fritah, S., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00576-y · Cited by 65
Fluorescence intensity and lifetime redox ratios detect metabolic perturbations in T cells
Hu, L., Wang, N., Cardona, E., & Walsh, A. J. (2020) · Biomedical Optics Express · doi:10.1364/boe.401935 · Cited by 61
Splicing factor SRSF1 is indispensable for regulatory T cell homeostasis and function
Katsuyama, T., & Moulton, V. R. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109339 · Cited by 58
FOXP3+ regulatory T cells and the immune escape in solid tumours
Qiu, Y., Ke, S., Chen, J., Qin, Z., Zhang, W., Yuan, Y., Meng, D., Zhao, G., Wu, K., Li, B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.982986 · Cited by 70
Controlling Salmonella: strategies for feed, the farm, and the processing plant
Obe, T., Boltz, T. P., Kogut, M. H., Ricke, S. C., Brooks, L. A., Macklin, K. S., & Peterson, A. (2023) · Poultry Science · doi:10.1016/j.psj.2023.103086 · Cited by 64
“…changes in intracellular metabolic pathways in immune cells, especially macrophages and T cells, during different environmental stimuli that altered their function (activation, proliferation) and regulated in fl ammation (Michalek et al., 2011; O ’ Neill and Hardie, 2013; O ’ Neill et al., 2016).”
BackgroundThe outliers become a stampede as immunometabolism reaches a tipping point
Nikolajczyk, B. S., Jagannathan‐Bogdan, M., & Denis, G. V. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01142.x · Cited by 58
“It is possible that the effector CD4 T cells’ preference for glycolytic metabolism (56) is fueled by the chronic elevated”
BackgroundResultPatsoukis, N., Weaver, J. D., Strauss, L., Herbel, C., Seth, P., & Boussiotis, V. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00330 · Cited by 60
Context-Dependent Pharmacological Effects of Metformin on the Immune System
Marcucci, F., Romeo, E. L., Caserta, C. A., Rumio, C., & Lefoulon, F. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.003 · Cited by 61
Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and diet
Zhao, S., Peralta, R. M., Avina-Ochoa, N., Delgoffe, G. M., & Kaech, S. M. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101485 · Cited by 67
The Role of Metabolic Dysfunction in T-Cell Exhaustion During Chronic Viral Infection
Zheng, K., Zheng, X., & Yang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843242 · Cited by 64
Metabolic regulation of T cell differentiation and function
Park, B. V., & Pan, F. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.027 · Cited by 61
“Tregs and memory T cells – fatty acid oxidation Although Tregs and memory T cells are distinct subsets, they share common metabolic requirements: FAO (Michalek et al., 2011; Pearce et al., 2009).”
BackgroundInfluentialThe bioenergetics of inflammation: insights into obesity and type 2 diabetes
Keane, K. N., Calton, E. K., Carlessi, R., Hart, P. H., & Newsholme, P. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.45 · Cited by 58
Immunosuppressive Amino-Acid Catabolizing Enzymes in Multiple Sclerosis
Correale, J. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.600428 · Cited by 56
miR-33 Silencing Reprograms the Immune Cell Landscape in Atherosclerotic Plaques
Afonso, M. S., Sharma, M., Schlegel, M., van Solingen, C., Koelwyn, G. J., Shanley, L. C., Beckett, L., Peled, D., Rahman, K., Giannarelli, C., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.317914 · Cited by 53
Control of T Cell Metabolism by Cytokines and Hormones
Bishop, E. L., Gudgeon, N. H., & Dimeloe, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.653605 · Cited by 61
Wan, X., & Garg, N. J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.693051 · Cited by 58
Mitochondrial impairment and repair in the pathogenesis of systemic lupus erythematosus
Zhao, L., Hu, X., Xiao, F., Zhang, X., Zhao, L., & Wang, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.929520 · Cited by 65
T Cells in Atherosclerosis: Key Players in the Pathogenesis of Vascular Disease
Hinkley, H., Counts, D. A., VonCanon, E., & Lacy, M. (2023) · Cells · doi:10.3390/cells12172152 · Cited by 66
“Glucose transporter1 (GLUT1) receptors, which import glucose to convert into pyruvate, are upregulated on the surface of T helper cell subsets [42].”
BackgroundChristie, D. A., Mitsopoulos, P., Blagih, J., Dunn, S. D., St‐Pierre, J., Jones, R. G., Hatch, G. M., & Madrenas, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103829 · Cited by 57
“Recent work has started to unravel the role of metabolic pathways in the differentiation of various T cell subsets (51, 60, 61).”
BackgroundSirtuin-2 Regulates Sepsis Inflammation in ob/ob Mice
Wang, X., Buechler, N. L., Martin, A., Wells, J. D., Yoza, B. K., McCall, C. E., & Vachharajani, V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160431 · Cited by 68
“Immune cells require activation of glycolysis for energy to generate an effector antimicrobial response and promote anabolic channels for growth and differentiation [43].”
BackgroundVaranasi, S. K., Donohoe, D. R., Jaggi, U., & Rouse, B. T. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700472 · Cited by 58
“4A, 4B, increasing glucose levels elevated the magnitude of Th1 responses, but had no significant influence on Treg responses, as noted previously (29, 30).”
BackgroundResultThe Role of T Cells in Herpes Stromal Keratitis
Rajasagi, N. K., & Rouse, B. T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00512 · Cited by 57
Immunometabolism of pro-repair cells
Singer, B. D., & Chandel, N. S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124613 · Cited by 54
Certo, M., Elkafrawy, H., Pucino, V., Cucchi, D., Cheung, K. C. P., & Mauro, C. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15002 · Cited by 53
“…withTh1, Th2, and Th17 cells, which are highly glycolytic and down-regulate FA oxidation, Tregs express low levels of GLUT1, use mitochondrial electron transport for proliferation, differentiation, and survival, and have high lipid oxidation rates (Michalek et al., 2011; Wang et al., 2011).”
BackgroundGlucose transporter 1 in rheumatoid arthritis and autoimmunity
Zezina, E. A., Sercan-Alp, Ö., Herrmann, M., & Biesemann, N. (2020) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1483 · Cited by 59
“For instance, GLUT1 expression is highest in Th17, Th2, and follicular helper T cells (TFH) cells, followed by Th1 cells (Michalek et al., 2011; Zeng et al., 2016).”
BackgroundInfluentialFatty acid metabolism in adaptive immunity
Zhou, X., Zhu, X., & Zeng, H. (2021) · FEBS Journal · doi:10.1111/febs.16296 · Cited by 73
Metadata
- Authors
- Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C.
- Affiliations
- Duke University (US)
- Duke Medical Center (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 186
- Issue
- 6
- Pages
- 3299-3303
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3198034
- OpenAlex
- W2157739158
- Cited by
- 2,091
- References
- 18
- Citations by year
- 2026: 116 · 2025: 133 · 2024: 168 · 2023: 163 · 2022: 214 · 2021: 215 · 2020: 209 · 2019: 167 · 2018: 147 · 2017: 164 · 2016: 122 · 2015: 88 · 2014: 69 · 2013: 55 · 2012: 47
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- Funders
- Cancer Research Institute
- Lupus Research Institute
- Leukemia and Lymphoma Society
- American Asthma Foundation
- Lupus Research Alliance
- National Institutes of Health
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (R01HL108006)
- National Institute of Allergy and Infectious Diseases (R01AI063345)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- effector T cells, regulatory T cells, glycolysis, lipid oxidation, glucose transporter 1, AMPK, Th1 cells, Th2 cells, Th17 cells, asthma, Treg generation, inflammatory diseases
- MeSH terms
- Animals, Asthma, Cell Survival, Cells, Cultured, Disease Models, Animal, Glycolysis, T-Lymphocytes, Helper-Inducer, Mice, Inbred C57BL, Mice, Transgenic, Lipid Peroxidation, Immunophenotyping, T-Lymphocyte Subsets, T-Lymphocytes, Regulatory, Glucose Transporter Type 1, Mice, AMP-Activated Protein Kinases, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.